Bill

Bill > HR586


US HR586

Vietnam Veterans Liver Fluke Cancer Study Act


summary

Introduced
01/21/2025
In Committee
02/25/2025
Crossed Over
04/08/2025
Passed
Dead

Introduced Session

119th Congress

Bill Summary

AN ACT To direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes.

AI Summary

This bill directs the Secretary of Veterans Affairs to conduct a comprehensive epidemiological study on cholangiocarcinoma (a rare type of bile duct cancer) among Vietnam War veterans. The study, to be initiated within 120 days of enactment and conducted in consultation with the Centers for Disease Control and Prevention, will analyze cancer incidence rates using the Veterans Affairs Central Cancer Registry and the National Program of Cancer Registries. Specifically, the study will identify the rate of cholangiocarcinoma among veterans who served in the Vietnam theater during the Vietnam era and compare it to the general U.S. population, breaking down the data by demographic characteristics such as age, gender, race, ethnicity, and geographic location. The Secretary is required to submit an initial report to Congress within one year of completing the study, including research findings and recommendations for potential administrative or legislative actions. Additionally, the bill mandates ongoing tracking of cholangiocarcinoma prevalence among Vietnam veterans and requires periodic follow-up reports to Congress. As a supplementary provision, the bill also extends a certain pension payment limitation deadline from November 30, 2031, to December 31, 2031.

Committee Categories

Health and Social Services, Military Affairs and Security

Sponsors (9)

Last Action

Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs. (on 04/08/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...